Orna Collaborates with Vertex to Develop Gene Therapies for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)

Shots: Orna & Vertex have entered into a 3yrs. strategic research collaboration to utilize the former’s LNP delivery solutions for supporting the development of next-gen. gene editing therapies for SCD & TDT, with Vertex funding the partnership As per the terms, Orna will get $65M upfront (incl. investment in the form of a convertible…

BySenior EditorJanuary 8, 2025

NEWS

JCR Pharmaceuticals and Modalis Progress into the Next Phase of Joint Research Agreement to Develop Gene Therapy

Shots: JCR Pharmaceuticals & Modalis have reported successful validation of initial PoC to develop gene therapy targeting CNS disease and will advance to the next phase under a new joint agreement The new agreement aims at conducting preclinical studies for gene therapy using JCR's BBB-crossing J-Brain Cargo tech and for gene therapy payload using Modalis' CRISPR-GNDM…

ByDipanshu DixitJanuary 6, 2025

WEEKLY SNAPSHOT

PharmaShots Weekly Snapshots (December 30th, 2024 – January 03rd, 2025)

This week PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, MedTech, M&A, Biosimilars, Animal Health & Biotech. Check out our full report below: Novartis Reports Data from P-III (STEER) Study of Onasemnogene Abeparvovec to Treat Children and Young Adults with Spinal Muscular Atrophy (SMA) Read More: Novartis CARsgen Therapeutics Reports Topline Results from P-II…

BySenior EditorJanuary 3, 2025

NEWS

Pharmanovia Collaborates with Radius Health to Commercialize Abaloparatide for Osteoporosis Treatment

Shots: Pharmanovia has signed an exclusive in-licensing agreement with Radius Health for abaloparatide (US brand name: Tymlos) to treat osteoporosis, expanding its osteoporosis franchise Pharmanovia will handle clinical, regulatory & commercial responsibilities across APAC region (China, Singapore, Thailand, Indonesia, Vietnam, Taiwan, Hong Kong, Malaysia, Macau & Philippines), while Radius will get an upfront, regulatory…

BySenior EditorJanuary 3, 2025

NEWS

Innovent Biologics Collaborates with Roche to Develop IBI3009 for SCLC

Shots: Innovent & Roche have entered into a collaboration & exclusive license agreement for developing IBI3009 to treat advanced SCLC As per the terms, Roche secures exclusive worldwide rights to develop, manufacture & commercialize IBI3009 plus will lead full development after early-stage studies, conducted jointly. Innovent will get $80M upfront, up to $1B development…

ByRidhi RastogiJanuary 2, 2025

NEWS

Pfizer Teminates the Deal to Develop Giroctocogene Fitelparvovec for Hemophilia A with Sangamo Therapeutics

Shots: Sangamo regains rights to giroctocogene fitelparvovec (gene therapy for hemophilia A) as Pfizer ends their collaboration (effective Apr 21, 2025) & decids not to file BLA or MAA to pursue commercialization. Sangamo plans to seek a new partner The drug is in P-III (AFFINE) trial involving 75 adult males with severe hemophilia A…

BySenior EditorJanuary 1, 2025

NEWS

Brii Bio Signs an Agreement with VBI Vaccines to Acquire BRII-179’s IP Rights

Shots: Brii Bio & VBI Vaccines have signed an asset purchase agreement to acquire IP rights of BRII-179 (novel recombinant protein-based HBV immunotx., expressing Pre-S1, Pre-S2 & S HBV surface antigens) As per the terms, Brii will acquire BRII-179’s patents, know-how & associated materials for $18M (eliminating all future milestones & royalty obligations). Prior…

BySenior EditorJanuary 1, 2025

THOUGHTSPOT

The Role of Nurses in Medication Management and Patient Safety

In the complex and fast-paced world of healthcare, nurses stand at the forefront of patient care. Their role extends beyond basic patient management; they are critical in safeguarding patient health through effective medication management. This vital responsibility involves more than just administering drugs; it requires a deep understanding of pharmacological therapies, keen attention to detail,…

ByCarla AdamsJuly 22, 2024

EVENTS

Free Webinar: Beyond the Horizon: Exploring Competitive Insights in the Life Science and Pharma Sectors

“If you know the enemy and Know Yourself, you need not fear the results of a hundred battles” - Sun Tzu (Art of War) The quote above from The Art of War by Sun Tzu delves into the essence of our upcoming webinar. Embark on a journey of learning with PharmaShots! An exclusive webinar dedicatedly designed…

BySenior EditorSeptember 4, 2023

EVENTS

Exclusive Coverage: Global PHT Expo & Summit 2023

The 15th and 16th of February saw the Global PHT Expo & Summit taking place at the Hyatt Centric in New Delhi, India. Through Global PHT Summit, it was for the first time that the pharma, healthcare, and technology veterans, pioneers, and professionals converged on the same platform to impart their knowledge on the best & futuristic PHT practices. The theme of the event…

BySenior EditorFebruary 27, 2023

Orna Collaborates with Vertex to Develop Gene Therapies for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)

JCR Pharmaceuticals and Modalis Progress into the Next Phase of Joint Research Agreement to Develop Gene Therapy

PharmaShots Weekly Snapshots (December 30th, 2024 – January 03rd, 2025)

Pharmanovia Collaborates with Radius Health to Commercialize Abaloparatide for Osteoporosis Treatment

Innovent Biologics Collaborates with Roche to Develop IBI3009 for SCLC

Pfizer Teminates the Deal to Develop Giroctocogene Fitelparvovec for Hemophilia A with Sangamo Therapeutics

Brii Bio Signs an Agreement with VBI Vaccines to Acquire BRII-179’s IP Rights

The Role of Nurses in Medication Management and Patient Safety

Free Webinar: Beyond the Horizon: Exploring Competitive Insights in the Life Science and Pharma Sectors

Exclusive Coverage: Global PHT Expo & Summit 2023

Contact US

FOLLOW US